Search Results - "Poór, G."

Refine Results
  1. 1

    Risk factors for diffuse idiopathic skeletal hyperostosis: a case–control study by Kiss, C., Szilágyi, M., Paksy, A., Poór, G.

    Published in Rheumatology (Oxford, England) (01-01-2002)
    “…Objective. Diffuse idiopathic skeletal hyperostosis (DISH) is a skeletal disease characterized by ligamentous ossification of the anterolateral side of the…”
    Get full text
    Journal Article
  2. 2

    Reduced volumes of the CA1 and CA4-dentate gyrus hippocampal subfields in systemic lupus erythematosus by Bódi, N, Polgár, A, Kiss, E, Mester, Á, Poór, G, Kéri, S

    Published in Lupus (01-11-2017)
    “…Introduction There is evidence for hippocampal dysfunctions in systemic lupus erythematosus (SLE), which may contribute to neuropsychiatric impairments…”
    Get full text
    Journal Article
  3. 3

    Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to cost-effectiveness by Lakatos, P., Tóth, E., Szekeres, L., Poór, G., Héjj, G., Marton, I., Takács, I.

    Published in Osteoporosis international (01-08-2014)
    “…Summary The efficacy of interventions used in real life for the treatment of osteoporosis has not been evaluated on a national basis. We analysed the database…”
    Get full text
    Journal Article
  4. 4

    Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial by Poór, G., Strand, V.

    Published in Rheumatology (Oxford, England) (01-06-2004)
    “…Objective. To compare the efficacy and safety profile of two daily maintenance doses of leflunomide, 10 mg and 20 mg, for the treatment of active rheumatoid…”
    Get full text
    Journal Article
  5. 5

    Lack of genetic association of the Toll-like receptor 4 (TLR4) Asp299Gly and Thr399Ile polymorphisms with spondylarthropathies in a Hungarian population by GERGELY, P, BLAZSEK, A, WEISZHAR, Z, PAZAR, B, POOR, G

    Published in Rheumatology (Oxford, England) (01-10-2006)
    “…Bacteria have long been suggested as aetiological factors in the genetically susceptible host in spondylarthropathies, including ankylosing spondylitis (AS)…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis by Bucsi, László, Poór, Gyula

    Published in Osteoarthritis and cartilage (01-05-1998)
    “…Patients with osteoarthritis (OA) of the knee were treated with chondroitin sulfate (CS, Condrosulf R, IBSA, Lugano, CH) in a randomized, double-blind,…”
    Get full text
    Journal Article
  8. 8

    Determinants of reduced survival following hip fractures in men by Poór, G, Atkinson, E J, O'Fallon, W M, Melton, 3rd, L J

    Published in Clinical orthopaedics and related research (01-10-1995)
    “…To assess determinants of poor survival after hip fractures in men, a population-based cohort study was conducted among 131 men in Rochester, MN, who had their…”
    Get more information
    Journal Article
  9. 9
  10. 10

    International variation in the incidence of hip fractures: Cross-national project on osteoporosis for the world health organization program for research on aging by SCHWARTZ, A. V, KELSEY, J. L, NELSON, L. M, HEYSE, S. P, MAGGI, S, TUTTLEMAN, M, HO, S. C, JONSSON, P. V, POOR, G, SISSON DE CASTRO, J. A, XU, L, MATKIN, C. C

    Published in Osteoporosis international (01-03-1999)
    “…A cross-national study of hip fracture incidence was carried out in five geographic areas--Beijing, China; Budapest, Hungary; Hong Kong; Porto Alegre, Brazil;…”
    Get full text
    Journal Article
  11. 11

    Effect of bisphosphonate treatment in patients with Paget's disease of the skull by Donáth, J., Krasznai, M., Fornet, B., Gergely, P., Poór, G.

    Published in Rheumatology (Oxford, England) (01-01-2004)
    “…Objectives. Hearing loss has long been known to be a complication of Paget's disease of bone. The aim of this study was to investigate Paget's disease of the…”
    Get full text
    Journal Article
  12. 12

    Vitamin D receptor, oestrogen receptor-α and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone by Donáth, J., Speer, G., Poór, G., Gergely, P., Tabák, A., Lakatos, P.

    Published in Rheumatology (Oxford, England) (01-06-2004)
    “…Objectives. The significance of genetic polymorphisms in the development of Paget's disease of bone is unclear at present. Methods. We analysed the BsmI…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Predictors of hip fractures in elderly men by Poór, Gyula, Atkinson, Elizabeth J., O'Fallon, W. Michael, Melton, L. Joseph

    Published in Journal of bone and mineral research (01-12-1995)
    “…To assess the influence on the risk of hip fractures in men of medical conditions associated with secondary osteoporosis or with an increased likelihood of…”
    Get full text
    Journal Article
  15. 15

    Comorbidity clusters in generalized osteoarthritis among female patients: A cross-sectional study by Kovari, E., Kaposi, A., Bekes, G., Kiss, Z., Kurucz, R., Mandl, P., Balint, G.P., Poor, G., Szendroi, M., Balint, P.V.

    Published in Seminars in arthritis and rheumatism (01-04-2020)
    “…•The summarized comorbidity count in the GOA group was almost twice that of the control group.•Cardiovascular comorbidities were notable in each GOA cluster,…”
    Get full text
    Journal Article
  16. 16

    Age-related hip fractures in men : clinical spectrum and short-term outcomes by POOR, G, ATKINSON, E. J, LEWALLEN, D. G, O'FALLON, W. M, MELTON, L. J

    Published in Osteoporosis international (01-01-1995)
    “…Clinical spectrum, treatment and short-term outcomes were assessed among the 131 Rochester, Minnesota, men who contracted an initial hip fracture due to…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Vitamin D receptor, oestrogen receptor-  and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone by Donath, J., Speer, G., Poor, G., Gergely, P., Tabak, A., Lakatos, P.

    Published in Rheumatology (Oxford, England) (01-06-2004)
    “…Objectives. The significance of genetic polymorphisms in the development of Paget's disease of bone is unclear at present. Methods. We analysed the BsmI…”
    Get full text
    Journal Article
  19. 19
  20. 20